- Filed
- Feb 14, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Feb 14, 2024 | 11.78M sh |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $27.51M |
| Short Term Investments | Q2 2024 · Jun 30, 2023 | $26.73M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $5.24M |
| Cash And Equivalents | Q2 2024 · Jun 30, 2023 | $12.24M |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $38.11M |
| Stockholders Equity | Q2 2024 · Jun 30, 2023 | $38.93M |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $12.96M |
| Current Liabilities | Q2 2024 · Jun 30, 2023 | $16.51M |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $12.96M |
| Total Liabilities | Q2 2024 · Jun 30, 2023 | $16.51M |
| Current Assets | Q2 2024 · Dec 31, 2023 | $47.82M |
| Current Assets | Q2 2024 · Jun 30, 2023 | $51.86M |
| Total Assets | Q2 2024 · Dec 31, 2023 | $52.59M |
| Total Assets | Q2 2024 · Jun 30, 2023 | $56.93M |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 11.7M sh |
| Shares Diluted | Q2 2024 · Dec 31, 2022 | 11.69M sh |
| Capex | Q2 2024 · Dec 31, 2022 | $45.48K |
| Operating Cash Flow restated | Q2 2024 · Dec 31, 2022 | −$7.1M |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.03 |
| Eps Diluted | Q2 2024 · Dec 31, 2022 | −$0.13 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.03 |
| Eps Basic | Q2 2024 · Dec 31, 2022 | −$0.13 |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $1.34M |
| Sga Expense | Q2 2024 · Dec 31, 2022 | $2.58M |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $976.42K |
| Rd Expense | Q2 2024 · Dec 31, 2022 | $1.95M |
| Net Income | Q2 2024 · Dec 31, 2022 | −$378.32K |
| Net Income | Q2 2024 · Dec 31, 2022 | −$1.51M |
| Net Income | Q2 2024 · Sep 30, 2022 | −$1.13M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$1.37M |
| Operating Income | Q2 2024 · Dec 31, 2022 | −$1.98M |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $946.04K |
| Gross Profit | Q2 2024 · Dec 31, 2022 | $2.54M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $8.04M |
| Cost Of Revenue | Q2 2024 · Dec 31, 2022 | $14.55M |